Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3220 results found

2026 ∙ Wasilewski, A. Serrafi, A.

Identification of metabolic signatures of immune response following mRNA and inactivated vaccines against COVID-19: a systematic review

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Low
2026 ∙ Kumar, A. R. Tariq, R. Rao, K. S.

Immunization Coverage among Children Under Five in India: A Meta-Analysis

  • South-East Asia
  • India
  • Newborn
  • Children
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Mahanty, B. Pattnaik, D. Sahoo, M.

Immunization Coverage and Dropout Rates Under the Universal Immunization Programme: A Systematic Review and Meta-Analysis

  • South-East Asia
  • India
  • Newborn
  • Children
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Mercado, V. J. Contreras, D. L. Wongnak, P. Yamin, F. Y. Chatchen, S. Ngamprasertchai, T. Pan-ngum, W.

Immunization gaps and measles outbreaks in ASEAN (2015-2025): A systematic review and meta-analysis

  • South-East Asia
  • Western Pacific
  • All age groups
  • Measles
  • Coverage
  • Administration
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Zarro, M. Bashlakova, K. Dellisanti, B. Brunone, S. Villari, P. De Vito, C. Rosso, A.

Immunogenicity and safety of Ebola vaccines in children: A systematic review and meta-analysis

  • Newborn
  • Children
  • Adolescents
  • Ebola
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2026 ∙ Boene, J. L. Campos, L. R. Carpi, G. C. Muhawenimana, M. Machado, S. H. de Deus, N. Bauhofer, A. F. L.

Immunogenicity and safety of novel oral polio vaccine type 2 (nOPV2) in pediatric populations: a systematic review and Bayesian meta-analysis

  • Newborn
  • Children
  • Poliomyelitis
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2026 ∙ Hussain, M. Hassan, M. Athar, M. Khan, S. Azam, M. T. Rathi, D. Nawaz, J.

Immunogenicity and safety of Sabin-strain inactivated poliovirus vaccine in infants: a systematic review and meta-analysis

  • Newborn
  • Children
  • Poliomyelitis
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2026 ∙ Bazargaliyev, Y. S. Kurmangaliyeva, S. S. Kudabayeva, K. I. Abilov, T. S. Madenbayeva, A. M.

Impact of COVID-19 vaccination on the risk of long COVID: An umbrella review of meta-analyses

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Chen, X. Tavlian, S. Carville, K. S. Tellioglu, N. Spirkoska, V. Carvalho, N. Price, D. J. Campbell, P. T. McVernon, J.

Impact of CRM197-based conjugate vaccines, schedules, and regions on pneumococcal immunogenicity in young children: systematic review

  • Newborn
  • Children
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2026 ∙ Maiorano, M. F. P. Cazzolla, A. Maiorano, B. A. Loizzi, V. Cormio, G. Colonna, G. Lopez, S.

Impact of HPV vaccine on CIN2+ recurrence after conization: a systematic review and meta-analysis of vaccination timing, valency and surgical margins

  • All age groups
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
Loading...